Our own blood is still the best thing to have in our veins

Current Opinion in Anaesthesiology

Volumn 21, Issue 5, 2008, Pages 657-663

  Frenzel, Tim ^a   Van Aken, Hugo ^a   Westphal, Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA SUBSTITUTE;

BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL TRIAL; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; LEUKOCYTE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SURGICAL MORTALITY; TREATMENT OUTCOME; VEIN;

BLOOD TRANSFUSION, AUTOLOGOUS; BLOOD VOLUME; COLLOIDS; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; ISOTONIC SOLUTIONS; PRACTICE GUIDELINES AS TOPIC; SERUM ALBUMIN;

EID: 53549115914     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283103e84     Document Type: Note

References (60)

1. Goodnough LT. Risks of blood transfusion. Crit Care Med 2003; 31 :S678-S686.
2. Spence RK, Alexander JB, DelRossi AJ, et al. Transfusion guidelines for cardiovascular surgery: lessons learned from operations in Jehovah's Witnesses. J Vasc Surg 1992; 16:825-829; discussion 829-831.
3. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34:396-401.
4. Gohel MS, Bulbulia RA, Slim FJ, et al. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 2005; 87:3-14.
5. Hebert PC, Wells G, Martin C, et al. Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 1999; 3:57-63.
6. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:S27-S86.
7. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81:1650-1657.
8. Hebert PC, Wells G, Blajchman MA, et al. A rnulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
9. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 2006; 103:15-20; table of contents.
10. Murphy GJ, Reeves BC, Rogers CA. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552.
11. Tinmouth A, Fergusson D, Yee IC, et al. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46:2014-2027.
12. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29:227-234.
13. Vincent JL, Sakr Y, Sprung C, et al. Are blood transfusions associated with greater mortality rates? Results of the sepsis occurrence in acutely ill patients study. Anesthesiology 2008; 108:31-39.
14. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5:253-259.
15. Baatard R, Dantal J, Hourmant M, et al. Effect of the number of pregraft blood transfusions in kidney graft recipients treated with bioreagents and cyclosporin A. Transpl Int 1991; 4:235-238.
16. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;CD005033.
17. BPAC recommends universal leukoreduction. AABB Newsbriefs. 1998; 20:16.
18. Sachs UJ. Pathophysiology of TRALI: current concepts. Intensive Care Med 2007; 33 (Suppl 1):S3-S11.
19. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1703-1721.
20. Fransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116:1233-1239.
21. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
23. Sweeney JD. Universal leukoreduction of cellular blood components in 2001 ? Yes. Am J Clin Pathol 2001; 115:666-673.
24. Wallis JP, Chapman CE, Orr KE, et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002; 42:1127-1134.
25. van Hilten JA, van de Watering LM, van Bockel JH, et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ 2004; 328:1281.
26. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996; 112:494-500.
27. Alexiou C, Tang AA, Sheppard SV, et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study. Eur J Cardiothorac Surg 2004; 26:294-300.
28. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289:1941-1949.
29. Roddie PH, Turner ML, Williamson LM. Leucocyte depletion of blood components. Blood Rev 2000; 14:145-156.
30. Dzik S, Aubuchon J, Jeffries L, et al. Leukocyte reduction of blood components: public policy and new technology. Transfus Med Rev 2000; 14:34-52.
31. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221.
32. Hebert PC, McDonald BJ, Tinmouth A. Clinical consequences of anemia and red cell transfusion in the critically ill. Crit Care Clin 2004; 20:225-235.
33. Carson PE, Tarlov AR. Biochemistry of hemolysis. Annu Rev Med 1962; 13:105-126.
34. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104:17063-17068.
35. Reynolds JD, Ahearn GS, Angelo M, et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 2007; 104:17058-1 7062.
36. Sakr Y, Chierego M, Piagnerelli M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007; 35:1639-1644.
37. Koch CG, Li L, Sessler Dl, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-1239.
38. Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46:1490-1495.
39. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292:1555-1562.
40. Reiles E, Van der Linden P. Transfusion trigger in critically ill patients: has the puzzle been completed? Crit Care 2007; 11:142.
41. Escobar GA, Cheng AM, Moore EE, et al. Stored packed red blood cell transfusion up-regulates inflammatory gene expression in circulating leukocytes. Ann Surg 2007; 246:129-134.
42. Pietersz RN, van der Meer PF, Seghatchian MJ. Update on leucocyte depletion of blood components by filtration. Transfus Sci 1998; 19:321-328.
43. Frenzel T, Sibrowski W, Westphal M. Red-cell storage and complications of cardiac surgery. N Engl J Med 2008; 358:2841 ; author reply 2841-2841 ; author reply 2842.
44. Adams RC, Lundy JS. Anesthesia in cases of poor surgical risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet 1942; 74:1011-1019.
45. Chapter CK, Cain SM. The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol 1986; 64:7-12.
46. Isaacs D, Fitzgerald D. Seven alternatives to evidence based medicine. BMJ 1999; 319:1618.
47. Klein HG, Spann DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007; 370:415-426.
48. Leung JM, Weiskopf RB, Feiner J, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 2000; 93:1004-1010.
49. Weiskopf RB, Feiner J, Hopf H, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006; 104:911-920.
50. Tircoveanu R, Van der Linden P. Hemodilution and anemia in patients with cardiac disease: what is the safe limit? Curr Opin Anaesthesiol 2008; 21:66-70.
51. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
52. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916.
53. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
54. Zander R, Boldt J, Engelmann L, et al. The design of the VISEP trial. Critical appraisal. Anaesthesist 2007; 56:71-77.
55. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98:216-224.
56. Boldt J, Brenner T, Lehmann A, et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 2003; 29:763-769.
57. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256.
58. Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modem hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007; 35:2740-2746.
59. Boldt J, Papsdorf M. Fluid management in burn patients: results from a European survey: more questions than answers. Burns 2008; 34:328-338.
60. Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 2002; 30:300-305.